Alternative pacing strategies for optimal cardiac resynchronization therapy
Juan Hua1, Qiling Kong1, Qi Chen1
1Department of Cardiology, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Frontiers in Cardiovascular Medicine
|October 14, 2022
Summary
New pacing strategies like His bundle pacing and left bundle branch area pacing offer alternatives to traditional biventricular pacing for cardiac resynchronization therapy, improving outcomes in challenging cases.
Area of Science:
- Cardiology
- Electrophysiology
- Medical Devices
Background:
- Conventional cardiac resynchronization therapy (CRT) using biventricular pacing (BVP) has limitations including lead placement complications and a significant non-response rate.
- Challenges with BVP necessitate exploration of alternative pacing strategies for improved CRT effectiveness.
Purpose of the Study:
- To review the current state and advancements in alternative pacing methods for CRT.
- To compare His bundle pacing (HBP), left bundle branch area pacing (LBBAP), and leadless left ventricular pacing against conventional CRT.
Main Methods:
- Review of clinical studies and recent progress in HBP, LBBAP, and leadless LV pacing.
- Focus on overcoming limitations of conventional CRT and lead implantation.
Main Results:
- HBP shows promise but faces implantation challenges and variable thresholds.
- LBBAP demonstrates comparable electrical resynchronization to HBP with simpler implantation and better stability.
- Leadless LV pacing offers an effective solution for challenging patient groups.
Conclusions:
- HBP, LBBAP, and leadless LV pacing are emerging alternatives for failed or non-responsive CRT.
- These novel techniques aim to improve CRT efficacy and patient outcomes by addressing limitations of BVP.
Related Concept Videos
01:22Heart Failure VI: Adjunct Therapies
25
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
25
01:25Dysrhythmias VI: Management of Dysrhythmias
103
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
103
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
65
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
65
01:29Cardiomyopathy V: Interprofessional Care
27
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
27
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
37
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
37
01:30Pulse rhythm
900
Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
900